
80 Acres Farms Raises $115M, Acquires Plantae Biosciences
Key Highlights:
- 80 Acres Farms raises $115 million in capital amid strong investor confidence.
- Acquires Plantae Biosciences, an Israeli biotech company specializing in accelerated plant breeding.
- Strategic investors include General Atlantic, Siemens Financial Services, Barclays Climate Ventures, and more.
- Plantae's research collaboration with Weizmann Institute brings cutting-edge plant breeding to Infinite Acres.
- Continued growth in 2024 with new retail expansions, ingredient channels, and a 60% revenue CAGR.
Source: Newswire
Quotes
“ “Our ability to raise capital in today’s market speaks to the confidence investors have in the need for controlled environment agriculture and our vision and execution.” ”
Mike Zelkind, CEO & Co-founder at 80 Acres Farms
Why This Matters:
This milestone strengthens 80 Acres Farms' position as a leader in controlled environment agriculture, leveraging advanced genetics and precision farming to improve crop yield, sustainability, and food security. The acquisition of Plantae Biosciences unlocks new innovations in plant breeding, helping tailor crops for better taste, nutrition, and resilience to climate change. With strong investor backing and continued expansion, 80 Acres Farms is shaping the future of food production.